Study S002549

A Pilot Study on Creatine Supplementation During Resistance-training for Prevention of Lean Tissue Mass Loss During GLP-1 Receptor Agonist Therapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07625202
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 40
Start: 2026-05-25
Primary completion: 2027-05-30
Lead sponsor: University of Saskatchewan
Conditions: Sarcopenia
Interventions: DIETARY_SUPPLEMENT:Dietary supplementation during a 12 week resistance-training program (creatine); DIETARY_SUPPLEMENT:Dietary supplementation during a 12 week resistance-training program (placebo)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in sit to stand performance (number of times) [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.